This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Bifidobacterium longum
- DrugBank Accession Number
- DB19248
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Investigational
- Synonyms
- B. longum
- Bifidobacterium longum reuter, 1963
- Bifidobacterium longum whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Baktera Voyage Bifidobacterium longum (700000000 unit) + Lactobacillus acidophilus (1200000000 unit) + Lactobacillus casei (100000000 unit) Capsule Oral Les Laboratoires Suisse Inc. 2004-04-01 2009-08-05 Canada 
Intestalife Bifidobacterium longum (0.2 b) + Lacticaseibacillus rhamnosus (3.4 b) + Lactobacillus acidophilus (0.4 b) Capsule Oral Holista Health (Canada) Inc. 1997-09-04 2006-08-24 Canada Probiotic Bifidobacterium longum (1 b / cap) + Lactobacillus acidophilus (3 b / cap) Capsule Oral Holista Health (Canada) Inc. 1997-04-15 2003-07-30 Canada Quick-Acting Wart Removal Bifidobacterium longum (1 mg/100mL) + Glycyrrhizinate dipotassium (0.2 mg/100mL) + Salicylic acid (20 mg/100mL) + Salix alba bark (2 mg/100mL) Liquid Cutaneous Shenzhenshi Liuxiang Yuntian Network Technology Co., Ltd. 2023-07-12 Not applicable US 
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 831AQW699W
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- 1150096
- Wikipedia
- Bifidobacterium_longum
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Health Services Research Microbiota 1 somestatus stop reason just information to hide Not Available Completed Treatment Irritable Bowel Syndrome (IBS) 1 somestatus stop reason just information to hide Not Available Not Yet Recruiting Supportive Care Breast Cancer 1 somestatus stop reason just information to hide 4 Completed Other Allergic Rhinitis (AR) 1 somestatus stop reason just information to hide 4 Completed Prevention Antibiotic Associated Diarrhoea / Clostridium Difficile (C. Difficile) / Diarrhea / Infection / Ventilator Associated Bacterial Pneumonia (VABP) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule, coated Oral 400 million CFU Capsule Oral Liquid Cutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 11, 2024 18:13 / Updated at July 16, 2024 15:22